Connect with us

Featured Stocks

County Line Energy (OTC: CYLC): This Hidden Gem Grows More Than Just Weed

Published

on

OTC: CYLC

County Line Energy Corp. (OTC: CYLC) could be the next pot stock to hit the JACK POT as the company aggressively carves out a household name for itself in the legal marijuana arena!

Many slang words have evolved over the years for marijuana, but it doesn’t matter what you call it. 

What matters is that cannabis, Mary Jane, ganja, etc., has evolved into a colossal sector that is worth billions upon billions of dollars.

This is an industry that has created massive business opportunities and has provided health benefits to a slew of people who suffer from a range of disorders including depression, insomnia, pain, PTSD, and even serious diseases like cancer. 

There is no doubt that legal marijuana is a boom to the economy, bringing salvation to states that are now able to generate massive revenue from taxes. 

Colorado, one of the first states to legalize the drug, has money pouring in from its legal recreational marijuana sales. The state surpassed a whopping $1 billion in tax revenue this year since recreational use was legalized in 2014!

Support for legalizing the plant has also reached an all-time high in America according to the latest Gallup poll and every Democrat running for president in 2020 is now in favor of marijuana legislation on a federal level. Prohibition in America could be on its very last legs!

It has been estimated that 1/3rd of America’s marijuana is now grown inside according to motherjones.com. and this is what could help make County Line Energy Corp. (OTC: CYLC) one of the most opportunistic plays on Wall Street!

With its acquisition of Grow Box 5000, County Line Energy Corp. (OTC: CYLC) may quickly become the go to source for cannabis growing all over!

Through its wholly-owned operating subsidiary D5 Partners, Inc., County Line Energy Corp. (OTC: CYLC) is the developer and distributor of the Grow Box 5000 family of self-contained, fully automated, and expandable smart hydroponics systems for use in growing plants and vegetables. 

The company’s mission is to customize ecosystems that enable you to grow your own vegetables, hemp and cannabis in the most advanced way possible.

One in 3 households are now growing food — this the highest overall participation and spending levels that have been seen in a decade according to the company. 

Millennials represent a big chunk of this segment, moving from 8 million growers in 2008 to 13 million in 2013.

An exciting aspect about the company’s self-contained growing systems is that they could become a household name in cannabis cultivation in doors!

GROW BOX 5K was created with a focus on creating a platform that promotes indoor Cannabis production on all scales.

Cannabis cultivation today is a lot different than what it was decades ago where people cultivated the drug in secrecy. Hidden buildings, or deep forests were the only choices for many to grow marijuana.

Today people can grow it from their own homes and control their growing right from their smart phones. This is a high-tech world and cannabis growing can be simple and easy to do because of it.

The GROW BOX 5K is fully automated and can be controlled from your smartphone which means you can set it up and walk away. Multiple Grow Boxes can also be linked together and controlled from a single interface.

Product highlights include: Easy to use, saves users money, fully automated, and have the best technology and construction. 

Competitively priced starting at $1,499, the system features high quality 20″ x 20″ x 44″ stainless steel, aluminum, and high-grade plastics structure. It also come switch automatic temperature control, automatic LED lighting control, automatic watering/feeding control, and semi-automatic water refill and drain capability.

HEPA filters facilitate the intake of pest and bacteria-free fresh air and activated charcoal filters clean and exhaust scrubbed odorless air. The controlled systems are also Wi-fi enabled and feature camera capabilities to view and share your grow progress from any smartphone or PC.

The system is also easily upgradeable and expandable and available in multiple exterior finishes to match most any room decor.

“Grow Box 5000 represents the cumulative expertise of over 30 years of building highly complicated machines and products for consumers across the globe.  The Grow Box 5000 series incorporates decades of professional growing know-how into an attractive, yet powerful design, that’s fully automated and easy to use, from the comfort of your own home, and completely controlled from your computer or smartphone.”

Eric Dena, D5 Partners, Inc. CEO and Grow Box 5000 co-creator, has said:

“We are confident that many potential growers, particularly in the rapidly expanding regulated and legalized cannabis and medical marijuana space, will embrace this technology to automate and simplify their personal-scale operations.”

According to GreenCoastHydroponics.com, the GROW BOX 5k “is the most advanced Grow System” they have ever seen!

The company just recently gave the green light to the phase 2 development of the Grow Box 5000.

With Phase 1 complete, County Line Energy Corp. (OTC: CYLC) has decided to move to Phase 2, which includes fully automated systems for advanced growing and management prototypes.  

“We expect to deliver the fully automated machines 1st quarter 2020.  These systems will contain software to assist in controlling the environment of the GB5K to ensure the highest yields possible, regulating lighting, water, and atmospheric changes.”

The GB5K units can be custom skinned to integrate with any type of home décor. Further, it will be available in a variety of sized to ensure households of any size will have the most efficient outcome.

According to the Marijuana Business Factbook, retail sales of medical and recreational cannabis in the United States are on pace to eclipse $12 billion by the end of this year. This would be an increase of roughly 35% over 2018.

Retail sales could rise as high as $30 billion by 2023!

It was a banner year in 2018 with investors pouring an amazing $10 billion into cannabis in North America.

There has been a tremendous amount of positive buzz surrounding the legal marijuana industry, especially with politician on board to decriminalize the plant. This has helped marijuana stocks witness supreme rallies in recent years.

When the Food and Drug Administration approves the first pharmaceutical drug made from cannabis, it says something. When Corona Beer’s owner makes a $4 billion bet on a marijuana firm called Canopy Growth it says something. 

When one marijuana company called Tilray Inc. sees its shares explode from under $60 to over $200 in just three weeks after making its debut in the market, it says something. 

When one analyst predicts that legal marijuana could soon become a bigger industry than soda, it says something.

One of the top marijuana analysts, Vivien Azer at Cowen, is also calling for total U.S. cannabis sales to hit $80 billion by 2030!

Although competitors exist in the market such as Leaf, Grobo, Trim, leaf, Home Grow Rooms/Tents, Aero Garden, and Miracle-Gro, D5 partners have competitive advantage over them on the basis of broader experience in global manufacturing with a very strong background in bringing commercial products to consumers. 

Moreover, the company does not need to rely on subcontractors and vendors to construct and design the products and most of the skills required are in-house.

Hemp is also said to have enormous environmental, economic, and commercial potential and growers could be looking at County Line Energy Corp. (OTC: CYLC) for their needs. The 2018 Farm Bill was passed last year, and it legalized the regulated production of hemp.

The 2018 National Gardening Survey found that an astonishing 15% of US households would grow marijuana at home if it was legal. 

A survey from Yahoo News and Marist College, has additionally illustrated just how mainstream marijuana has become. Nearly 55 million adults currently use the drug. Let’s face it, we are in a MARIJUANA REVOLUTION!

Over the years, research has yielded results that indicate marijuana may be beneficial in the treatment of many conditions including chronic pain, drug addiction, anxiety, PTSD, neurological disorders, and cancer. 

What do all of these things say? That marijuana is here to stay and that pot stocks could be heading even higher. 

Marijuana is not a taboo topic anymore and companies are generating stellar profits from the plant. Canadian marijuana producer Aurora Cannabis recently reported that it saw a 349% year-over-year increase in revenue!

It was only last October that County Line Energy Corp. (OTC: CYLC) launched public pre-orders for its flagship Grow Box 5000 self-contained smart hydroponics systems.

The company looks determined to become recognized in the legal cannabis space and has recently announced the formation and launch of a marketing and social media team. 

These are still the very early stages for the company and current share prices could be screaming opportunity… This is one pot stock that could soon be unstoppable as traders get it on their radar!

County Line Energy Corp. (OTC: CYLC) may be one of the next stocks to explode as Wall Street learns about the Grow Box 5000 and its potential in the monstrous legal marijuana sector!

DISCLAIMER
DISCLAIMER – THIS NEWSLETTER IS A PAID ADVERTISEMENT, NOT A RECOMMENDATION NOR AN OFFER TO BUY OR SELL SECURITIES. THIS NEWSLETTER IS OWNED, OPERATED AND EDITED BY ARCHANGEL MEDIA CONSULTING, LLC.  ANY WORDING FOUND IN THIS E-MAIL OR DISCLAIMER REFERENCING TO “I” OR “WE” OR “OUR” OR “ARCHANGEL MEDIA” REFERS TO ARCHANGEL MEDIA CONSULTING, LLC.  OUR BUSINESS MODEL IS TO BE FINANCIALLY COMPENSATED TO MARKET AND PROMOTE SMALL PUBLIC COMPANIES.  BY READING OUR NEWSLETTER AND OUR WEBSITE YOU AGREE TO THE TERMS OF OUR DISCLAIMER, WHICH ARE SUBJECT TO CHANGE AT ANY TIME. WE ARE NOT REGISTERED OR LICENSED IN ANY JURISDICTION WHATSOEVER TO PROVIDE INVESTMENT ADVICE OR ANYTHING OF AN ADVISORY OR CONSULTANCY NATURE AND ARE THEREFORE ARE UNQUALIFIED TO GIVE INVESTMENT RECOMMENDATIONS. ALWAYS DO YOUR OWN RESEARCH AND CONSULT WITH A LICENSED INVESTMENT PROFESSIONAL BEFORE INVESTING. THIS COMMUNICATION IS NEVER TO BE USED AS THE BASIS OF MAKING INVESTMENT DECISIONS AND IS FOR ENTERTAINMENT PURPOSES ONLY. AT MOST, THIS COMMUNICATION SHOULD SERVE ONLY AS A STARTING POINT TO DO YOUR OWN RESEARCH AND CONSULT WITH A LICENSED PROFESSIONAL REGARDING THE COMPANIES PROFILED AND DISCUSSED. CONDUCT YOUR OWN RESEARCH. COMPANIES WITH A LOW PRICE PER SHARE ARE SPECULATIVE AND CARRY A HIGH DEGREE OF RISK, SO ONLY INVEST WHAT YOU CAN AFFORD TO LOSE. BY USING OUR SERVICE YOU AGREE NOT TO HOLD OUR SITE, ITS EDITOR’S, OWNERS, OR STAFF LIABLE FOR ANY DAMAGES, FINANCIAL OR OTHERWISE, THAT MAY OCCUR DUE TO ANY ACTION YOU MAY TAKE BASED ON THE INFORMATION CONTAINED WITHIN OUR NEWSLETTERS OR ON OUR WEBSITE. 
WE DO NOT ADVISE ANY READER TO TAKE ANY SPECIFIC ACTION. LOSSES CAN BE LARGER THAN EXPECTED IF THE COMPANY EXPERIENCES ANY PROBLEMS WITH LIQUIDITY OR WIDE SPREADS. OUR WEBSITE AND NEWSLETTER ARE FOR ENTERTAINMENT PURPOSES ONLY. NEVER INVEST PURELY BASED ON OUR ALERTS. GAINS MENTIONED IN OUR NEWSLETTER AND ON OUR WEBSITE MAY BE BASED ON END-OF-DAY OR INTRADAY DATA. THIS PUBLICATION AND THEIR OWNERS AND AFFILIATES MAY HOLD POSITIONS IN THE SECURITIES MENTIONED IN OUR ALERTS, WHICH WE MAY SELL AT ANY TIME WITHOUT NOTICE TO OUR SUBSCRIBERS, WHICH MAY HAVE A NEGATIVE IMPACT ON SHARE PRICES. ARCHANGEL MEDIA’S BUSINESS MODEL IS TO RECEIVE FINANCIAL COMPENSATION TO PROMOTE PUBLIC COMPANIES.  WE HAVE BEEN COMPENSATED A FEE OF SEVENTY-FIVE THOUSAND US DOLLARS VIA BANK WIRE FOR A ONE-MONTH CYLC AWARENESS CAMPAIGN BY A THIRD PARTY, BLUE DIAMOND EQUITIES, LLC. PREVIOUSLY, WE WERE COMPENSATED TWO HUNDRED THOUSAND DOLLARS BY A THIRD PARTY, BLUE DIAMOND EQUITIES, LLC. THIS COMPENSATION IS A MAJOR CONFLICT OF INTEREST IN OUR ABILITY TO BE UNBIASED REGARDING. THEREFORE, THIS COMMUNICATION SHOULD BE VIEWED AS A COMMERCIAL ADVERTISEMENT ONLY. WE HAVE NOT INVESTIGATED THE BACKGROUND OF THE HIRING THIRD PARTY OR PARTIES.  ANY NON-COMPENSATED ALERTS ARE PURELY FOR THE PURPOSE OF EXPANDING OUR DATABASE FOR THE BENEFIT OF OUR FUTURE FINANCIALLY COMPENSATED INVESTOR RELATIONS EFFORTS. FREQUENTLY COMPANIES PROFILED IN OUR ALERTS MAY EXPERIENCE A LARGE INCREASE IN VOLUME AND SHARE PRICE DURING THE COURSE OF INVESTOR RELATIONS MARKETING, WHICH MAY END AS SOON AS THE INVESTOR RELATIONS MARKETING CEASES. THE INVESTOR RELATIONS MARKETING MAY BE AS BRIEF AS ONE DAY, AFTER WHICH A LARGE DECREASE IN VOLUME AND SHARE PRICE IS LIKELY TO OCCUR. OUR EMAILS MAY CONTAIN FORWARD-LOOKING STATEMENTS, WHICH ARE NOT GUARANTEED TO MATERIALIZE DUE TO A VARIETY OF FACTORS.
WE DO NOT GUARANTEE THE TIMELINESS, ACCURACY, OR COMPLETENESS OF THE INFORMATION ON OUR SITE OR IN OUR NEWSLETTERS. THE INFORMATION IN OUR EMAIL NEWSLETTERS AND ON OUR WEBSITE IS BELIEVED TO BE ACCURATE AND CORRECT, BUT HAS NOT BEEN INDEPENDENTLY VERIFIED AND IS NOT GUARANTEED TO BE CORRECT. THE INFORMATION IS COLLECTED FROM PUBLIC SOURCES, SUCH AS THE PROFILED COMPANY’S WEBSITE AND PRESS RELEASES, BUT IS NOT RESEARCHED OR VERIFIED IN ANY WAY WHATSOEVER TO ENSURE THE PUBLICLY AVAILABLE INFORMATION IS CORRECT. FURTHERMORE, ARCHANGEL MEDIA OFTEN EMPLOYS INDEPENDENT CONTRACTOR WRITERS WHO MAY MAKE ERRORS WHEN RESEARCHING INFORMATION AND PREPARING THESE COMMUNICATIONS REGARDING PROFILED COMPANIES. INDEPENDENT WRITERS’ WORKS ARE DOUBLE-CHECKED AND VERIFIED BEFORE PUBLICATION, BUT IT IS CERTAINLY POSSIBLE FOR ERRORS OR OMISSIONS TO TAKE PLACE DURING EDITING OF INDEPENDENT CONTRACTOR WRITER’S COMMUNICATIONS REGARDING THE PROFILED COMPANY(S). YOU SHOULD ASSUME ALL THE INFORMATION IN ALL OF OUR COMMUNICATIONS IS INCORRECT UNTIL YOU PERSONALLY VERIFY THE INFORMATION, AND AGAIN ARE ENCOURAGED TO NEVER INVEST BASED ON THE INFORMATION CONTAINED IN OUR WRITTEN COMMUNICATIONS. THE INFORMATION IN OUR DISCLAIMERS IS SUBJECT TO CHANGE AT ANY TIME WITHOUT NOTICE.

Featured Stocks

Decision Diagnostics Corp (OTCMKTS:DECN) Explodes On COVID-19 Test Kit Opportunity

Published

on

OTCMKTS:DECN

Decision Diagnostics Corp (OTCMKTS:DECN) is exploding higher after unveiling a new methodology for the screening of coronavirus. GenViroTM COVID-19 screening kit is the latest catalysts fuelling the stock’s price action activity in the market. Similarly, the stock has rallied by more than 300% as investors take note of the huge opportunity up for grabs as the coronavirus pandemic continues to cause havoc.

OTCMKTS:DECN Price Analysis

The ever-growing demand for coronavirus test kit presents a unique opportunity for the company to generate significant value. In return, investors have continued to push the stock higher even as the broader equity market continues to plunge into the bear territory.

OTCMKTS:DECN is currently trading in a steep uptrend after succumbing to bearish pressure in 2019. Given the strength of the upward momentum, the stock is closing in on its one-year highs as the break out shows no signs of slowing down. A rally followed by a close above the $0.08 mark should open the door for bulls to push the stock to two-year highs.

DECN Daily Chart

Similarly, the $0.05 mark is the immediate support level above which the stock remains a bull play. Conversely, a breach of the support level would leave Decision Diagnostics susceptible to further drops, probably back to the $0.03 level. However, given the developments on the global scene, the stock looks set to continue powering high on pullbacks.

About OTCMKTS:DECN

Decision Diagnostics bills itself…

Continue Reading

Featured Stocks

Is CytoDyn Inc. (OTCMKTS:CYDY) A Buy?

Published

on

CytoDyn

CytoDyn Inc (OTCMKTS:CYDY) has been making big moves lately, which have propelled the stock from December low of $0.270 to new highs. Notably, CytoDyn’s surge has come on significant volume as well, a clear sign of strong investor interest in the stock.

The excitement in CytoDyn stock that we are witnessing right now comes as the company has taken a leading role in the fight against the deadly Wuhan coronavirus. Moreover, investors have started pouring on CytoDyn stock as the company advances the development of its lead drug candidate as a treatment for about two dozen different cancer types.

Before we delve into the details, here is a brief profile of CytoDyn for those investors who may have just come across this company for the very first time.

About CytoDyn

CytoDyn operates in the healthcare sector as a biotechnology company. It is engaged in developing innovative treatments for a broad range of medical indications. Its lead product candidate is leronlimab (PRO 140). Clinical trials of leronlimab are ongoing for conditions such as HIV and multiple cancers with impressive results already attained. But CytoDyn is expanding its target conditions with leronlimab in the wake of the outbreak of the Wuhan coronavirus.

Here are some of the recent developments at CytoDyn that have excited renewed investor interest in its stock.

CytoDyn’s leronlimab under consideration as Wuhan potential coronavirus treatment

CytoDyn’s lead drug candidate leronlimab (PRO 140)…

Continue Reading

Featured Stocks

County Line Energy Corp. (OTC: CYLC) Could Soon Become the Next Household Name in the Actively Growing Legal Marijuana Space with its Revolutionary Grow Box Systems!

Published

on

OTC: CYLC

After a terrible 2019, pot stocks are positioned for a massive turn around this year and County Line Energy Corp. (OTC: CYLC) could experience one of the biggest bounces of them all!

There’s no denying that 2019 wasn’t the best year for marijuana-related stocks. In fact, pot stocks had a very sour year. From its March peak, the marijuana-focused ETFMG Alternative Harvest ETF (MJ) lost half its value before the year even ended.

But what a start to 2020 for cannabis on Wall Street… There has been a monstrous rebound already with marijuana-related ETF’s soaring!

In just one week in January the Horizons Marijuana Life Sciences Index ETF saw an increase of 19.11%, the ETFMG Alternative Harvest ETF gained 13.87%, and the Cannabis ETF advanced 16.9%. 

“Cannabis stocks seem to be slowly inching their way out of the bear market they’ve been in,” commented Debra Borchardt, CEO of Green Market Report. She added, “We’re seeing companies make adjustments to cultivation plans, restructuring debt and merge for strength as markets open more slowly than planned. Improvements in valuations are sure to ease the concerns of many investors.”

From an oversupply of marijuana and little progress towards federal level legalization, 2019 was a bust for the arena. 2020 however could be shaping up to become a tremendous year for cannabis stock gains. 

The industry is politically driven and this is an election year. It also helps that nearly all of the…

Continue Reading

MJ Stocks